Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers

Liver International

Volumn 32, Issue 7, 2012, Pages 1156-1164

  Xu, Jing ^a,d   Igarashi, Saya ^a,b   Sasaki, Motoko ^a   Matsubara, Takashi ^a,b   Yoneda, Norihide ^a,b   Kozaka, Kazuto ^b   Ikeda, Hiroko ^a   Kim, Jihun ^c   Yu, Eunsil ^c   Matsui, Osamu ^b   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c University of Ulsan College of Medicine   (South Korea)

^d SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Cirrhosis; Combined hepatocellular and cholangiocarcinoma; Dynamic imaging; Intrahepatic cholangiocarcinoma; Tumour vasculature

Indexed keywords

ADULT; AGED; ARTERY; ARTICLE; BILE DUCT CARCINOMA; CAPILLARY DENSITY; CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HEPATOCELLULAR CHOLANGIOCARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84863534818     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2012.02783.x     Document Type: Article

References (25)

1. Nakanuma Y, Curabo MP, Franceschi S, et al. A Intrahepatic cholangiocarcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, eds. WHO Classification of Tumours of the Digestive System; World Health Organization of Tumours, 4th edn. Lyon: IARC, 2010; 217-24.
2. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol 2002; 17: 1049-55.
3. Shaib YH, El-Serag HB, Nooka AK, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 2007; 102: 1016-21.
4. Nakanuma Y, Sato Y, Harada K, et al. Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. World J Hepatol 2010; 2: 419-27.
5. Nakanuma Y, Xu J, Harada K, et al. Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary, chronic advanced liver diseases. Pathol Int 2011; 61: 298-305.
6. Tomimatsu M, Ishiguro N, Taniai M, et al. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan. Cancer 1993; 72: 683-638.
7. Hai S, Kubo S, Yamamoto S, et al. Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma. Dig Surg 2005; 22: 432-9.
8. Vilana R, Forner A, Bianchi L, et al. Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology 2010; 51: 2020-9.
9. Xu J, Sasaki M, Harada K, et al. Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular-cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis. Histopathology 2011; 59: 1090-9.
10. Kozaka K, Sasaki M, Fujii T, et al. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'. Histopathology 2007; 51: 390-400.
11. Sasaki M, Tsuneyama K, Ishikawa A, Nakanuma Y. Intrahepatic cholangiocarcinoma in cirrhosis presents granulocyte and granulocyte-macrophage colony-stimulating factor. Hum Pathol 2003; 34: 1337-44.
12. Nakanuma Y, Sasaki M, Ikeda H, et al. Pathology of peripheral intrahepatic cholangiocarcinoma with reference to tumorigenesis. Hepatol Res 2008; 38: 325-34.
13. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: recent progress. Part 2: molecular pathology and treatment. J Gastroenterol Hepatol 2002; 17: 1056-63.
14. Chen LD, Xu HX, Xie XY, et al. Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Radiol 2008; 81: 881-9.
15. Xu HX, Lu MD, Liu GJ, et al. Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience. J Ultrasound Med 2006; 25: 23-33.
16. Nanashima A, Sumida Y, Abo T, et al. Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma. J Surg Oncol 2008; 9: 535-9.
17. Rimola J, Forner A, Reig M, et al. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology 2009; 50: 791-8.
18. Nakamura K, Zen Y, Sato Y, et al. Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver. Hum Pathol 2007; 38: 1532-46.
19. Pugacheva O, Matsui O, Kozaka K, et al. Detection of small hypervascular hepatocellular carcinomas by EASL criteria: comparison with double-phase CT during hepatic arteriography. Eur J Radiol 2011; 80: e201-6.
20. Hattori Y, Gabata T, Zen Y, et al. Poorly enhanced areas of pancreatic adenocarcinomas on late-phase dynamic computed tomography: comparison with pathological findings. Pancreas 2010; 39: 1263-70.
21. Celli N, Gaiani S, Piscaglia F, et al. Characterization of liver lesions by real-time contrast-enhanced ultrasonography. Eur J Gastroenterol Hepatol 2007; 19: 3-14.
22. Xu HX, Lu MD, Liu GJ, et al. Imaging of peripheral cholangiocarcinoma with low-mechanical index contrastenhanced sonography and SonoVue: initial experience. J Ultrasound Med 2006; 25: 23-33.
23. Sato S, Ohnishi K, Sugita S, Okuda K. Splenic artery and superior mesenteric artery blood flow: nonsurgical Doppler US measurement in healthy subjects and patients with chronic liver disease. Radiology 1987; 164: 347-52.
24. Kobayashi S, Nakanuma Y, Matsui O. Intrahepatic peribiliary vascular plexus in various hepatobiliary diseases: a histological survey. Hum Pathol 1994; 25: 940-6.
25. Okuda K. Hepatobiliary Diseases. Pathophyisology and Imaging. Oxford: Blackwell Science, 2001.